glaucoma and semaglutide may cause blindness—US study warning adds to growing debate on rare side effect Ophthalmic complications observed in patients
Description
Subramanian and Rusch describe in a letter in Movement Disorders why weight loss in Parkinson's disease remains under-recognized and why monitoring nutrition should become a routine part of care
Get back on track with proven guidance.
The incorporation of GLP-1 medications, coupled with lifestyle modifications, has maximized the reduction of obesity in adults
Hims promises an easier start to online GLP-1 treatment
Thyroid disorders affect millions seeking weight loss treatment
However, the use of GLP1-ra was associated with an increased risk of diabetic retinopathy in individuals with type 2 diabetes also taking insulin
